Your only mesothelioma treatments news source!
Click on each item to read full story.

 
Meso Foundation Congratulates National Cancer Institute Researcher for Prestigious Award
read story
The Mesothelioma Applied Research Foundation (Meso Foundation) congratulates former Science Advisory Board member and researcher at the National Cancer Institute, Raffit Hassan, MD, for receiving the prestigious Wagner Medal at the International Mesothelioma Interest Group (iMig) meeting last week. (PRWeb October 30, 2014) Read the full story at http://www.prweb.com/releases/2014/11 ...
 
Over $95,000 Raised for Mesothelioma Research at Pacific Meso Center's 3rd Annual Walk/Hike with Lead Sponsor ...
read story
SAN PEDRO, Calif., Oct. 17, 2014 /PRNewswire/ -- Pacific Meso Center's 3rd Annual Walk/Hike for Mesothelioma took place on Sunday, October 12th at the scenic Paramount Ranch in Agoura Hills. The event was attended by several mesothelioma patients, as well as over 250 participants, many of whom are friends and family of persons whose lives have been rocked by mesothelioma. There were also ...
 
Mesothelioma Victims Center Urges Diagnosed Victims Nationwide To Check Out Philadelphia's Fox Chase Cancer Center's ...
read story
While the Mesothelioma Victims Center might best be known for their efforts to make certain all diagnosed victims of mesothelioma get the best possible compensation for this asbestos related form of cancer, they are increasingly trying to create public awareness about top-notch cancer treatment centers in the United States that specialize in the treatment of mesothelioma. This week the group is ...
 
New Article Urges Mesothelioma Patients to Take Part in Clinical Trials, According to Surviving Mesothelioma
read story
A pair of Texas oncologists is encouraging mesothelioma patients to seek out and participate in clinical trials to improve the survival odds for themselves and future patients. (PRWeb October 04, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12219926.htm
 
U.S. Cancer Research Foundation Participates in International Conference for Cure and Prevention of Deadly Cancer
read story
Mary Hesdorffer, MS, APRN-BC, the executive director of the Mesothelioma Applied Research Foundation, is a presenter and chair of the nursing panel at the 12th International Mesothelioma Interest Group Conference in Cape Town, South Africa. (PRWeb October 21, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12265965.htm
 
Deadly Cancer Gets Media Coverage on Awareness Day
read story
On September 26th, Mesothelioma Awareness Day, the Mesothelioma Applied Research Foundation (Meso Foundation) and its volunteers received media coverage to shed light on this deadly cancer. (PRWeb September 30, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12213742.htm
 
The Mesothelioma Victims Center Shares Information About Bringham and Womens Hospital in Boston for World Class ...
read story
In an all-new approach this week to help mesothelioma victims find life-saving resources, the Mesothelioma Victims Center now points to Bringham and Womens Hospital in Boston as one of the nation's top facilities on the east coast for ground breaking treatment and surgical procedures designed to lengthen the life span of a victim for victims diagnosed in the early stages. For more information ...
 
Marshall Faulk, Thursday Night Football Host and NFL Hall of Famer, Boxing Legend Sugar Ray Leonard, Music Stars Brian ...
read story
LOS ANGELES, Oct. 29, 2014 /PRNewswire/ -- Thursday Night Football host and NFL Hall of Famer Marshall Faulk, Boxing Legend Sugar Ray Leonard, R&B Star Brian McKnight, Music Legend Stephen Stills, NFL ...
 
Survival rates for most cancers have improved in UK
read story
And for some types of tumour, survival rates have slid backwards despite millions of investment on treatment, Figures from the Office for National Statistics show.
 
Boehringer Ingelheim initiates global Phase III study investigating nintedanib in patients with colorectal cancer
read story
RIDGEFIELD, Conn., Oct. 21, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced enrollment of the first patient in a new global Phase III study in patients with metastatic colorectal cancer (mCRC). Colorectal cancer is the third most common cancer in the world, with nearly 1.4 million new cases diagnosed each year. LUME-COLON 1 [ClinicalTrials.gov identifier: NCT02149108] is a double-blind ...